Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported a decline in fourth quarter earnings even as revenues remained flat. The company withheld
Categories
Health Care
Infographic: Cigna Corporation (CI) Q1 2020 earnings results
Cigna Corporation (NYSE: CI) reported first quarter 2020 earnings results today. Total revenues amounted to $38.5 billion, reflecting a slight increase from
Align Technology Inc (NASDAQ: ALGN) Q1 2020 Earnings Call Transcript
Align Technology Inc (ALGN) Q1 2020 earnings call dated Apr. 29, 2020 Corporate Participants: Shirley Stacy -- Vice President of Corporate Communications & Investor
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q1 2020 Earnings Call Transcript
Vertex Pharmaceuticals Inc (VRTX) Q1 2020 earnings call dated Apr. 29, 2020 Corporate Participants: Michael Partridge -- Senior Vice President of Investor Relations Reshma
Vertex Pharmaceuticals (VRTX) reports Q1 2020 earnings results
Vertex Pharmaceuticals (Nasdaq: VRTX) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter
Humana Inc. (NYSE: HUM) Q1 2020 Earnings Call Transcript
Humana Inc. (HUM) Q1 2020 earnings call dated April 29, 2020 Corporate Participants: Amy Smith -- Investor Relations Bruce D. Broussard -- President and Chief Executive Officer
IQVIA Holdings Inc. (NYSE: IQV) Q1 2020 Earnings Call Transcript
IQVIA Holdings Inc. (IQV) Q1 2020 earnings call dated Apr. 28, 2020 Corportate Participants: Andrew Markwick -- Senior Vice President, Investor Relations and Treasury
Infographic: Anthem (ANTM) Q1 2020 Earnings Results
Anthem Inc. (NYSE: ANTM) reported a 2% decline in earnings for the first quarter of 2020 due to an increase in income
Infographic: Boston Scientific Corporation (BSX) Q1 2020 earnings results
Boston Scientific Corporation (NYSE: BSX) announced first quarter 2020 earnings results today. Sales grew 2% to $2.54 billion compared to the same
Cerner Corp (NASDAQ: CERN) Q1 2020 Earnings Call Transcript
Cerner Corp (CERN) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: David Brent Shafer -- Chairman andChief Executive Officer Marc Naughton -- Chief Financial
Waters Corporation (NYSE: WAT) Q1 2020 Earnings Call Transcript
Waters Corporation (WAT) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Bryan Brokmeier -- CFA, Senior Director Christopher J. O'Connell -- President and Chief
Accuray Inc (NASDAQ: ARAY) Q3 2020 Earnings Call Transcript
Accuray Inc (ARAY) Q3 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Joseph Diaz -- Managing Partner Joshua H. Levine -- President and Chief Executive
What to expect from Vertex Pharmaceuticals (VRTX) Q1 2020 earnings?
Biotechnology is the one industry that has been showing signs of improvement in the COVID-19 affected market. This week a bunch of
Neogenomics Inc (NASDAQ: NEO) Q1 2020 Earnings Call Transcript
Neogenomics Inc (NEO) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Douglas M. VanOort -- Chairman of the Board of Directors and
Pfizer (NYSE: PFE) Q1 2020 Earnings Call Transcript
Pfizer Inc. (PFE) Q1 2020 earnings call dated April 28, 2020 Corporate Participants: Chuck Triano -- Senior Vice President, Investor Relations Albert Bourla -- Chairman and
Merck & Co (NYSE: MRK) Q1 2020 Earnings Call Transcript
Merck & Co (MRK) Q1 2020 earnings call dated April 28, 2020 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations Kenneth C.
Centene Corp (NYSE: CNC) Q1 2020 Earnings Call Transcript
Centene Corp (CNC) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Jennifer Gilligan -- Senior Vice President, Finance & Investor Relations Michael
Merck (MRK) Q1 Earnings: Key quarterly numbers that you need to note down
Merck (NYSE: MRK) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter EPS
A visual representation of Pfizer Inc. (NYSE: PFE) Q1 2020 earnings results
Pfizer Inc. (NYSE: PFE) Tuesday reported a decline in first-quarter earnings and revenues. However, the results exceeded analysts' forecast. Earnings, on an
Lexicon Pharmaceuticals (NASDAQ: LXRX) Q1 2020 Earnings Call Transcript
Lexicon Pharmaceuticals (LXRX) Q1 2020 earnings call dated Apr. 27, 2020 Corporate Participants: Kimberly Lee -- Head of Investor Relations and Corporate Strategy Lonnel
Delay in filing Biogen’s Alzheimer’s drug leaves analysts scratching head during conference call
Late last year, Biogen (NASDAQ: BIIB) made an announcement that left investors gung-ho. The stock soared 27% after the company optimistically said